Scholars Central

Conference abstract

Durable biventricular support using right atrial placement

Authors: Hao A Tran, Travis L Pollema, Jorge Silva Enciso Barry H Greenberg, Denise D Barnard, Eric D Adler, Victor G Pretorius

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Patients with Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) levels 1–2 who either have or are at risk for right ventricular failure face significant morbidity and mortality after continuous flow left ventricular assist device (CF-LVAD) implantation. Currently, the options for biventricular support have limited the Total Artificial Heart (TAH; CardioWest, Syncardia, Tuscon, AZ) or Biventricular Assist Device (BiVAD), which uses bulky extracorporeal or implantable displacement pumps. We describe a successful series based on an innovative approach for biventricular support in consecutive INTERMACS levels 1–2 patients utilizing a Heart Ware Ventricular Assist Device (HVAD; Heart Ware, Framingham, MA) in a left ventricular (LVHVAD) and a right atrial (RA-HVAD) configuration. From June 2014 through May 2016, 11 consecutive INTERMACS levels 1–2 patients with evidence of biventricular failure underwent implantation of a CF LVAD (10 LV-HVAD and 1 HeartMate II LVAD, Thoratec, Pleasanton, CA) and RA-HVAD pumps. A total of 4,314 BiVAD support days were accumulated in our case series. Seven patients have undergone orthotopic heart transplant, whereas 3 are ambulatory and are either waiting transplant or reconsideration for transplantation. There is one mortality case in this case series, which was due to an intracranial bleed from supratherapeutic anticoagulation. Two other patients experienced hemorrhagic strokes, but without neurologic sequelae, whereas no patients have experienced ischemic strokes. There were two episodes of gastrointestinal bleeding. This is the largest series to date involving this approach with outcomes superior to those previously described in patients receiving biventricular support. We conclude this novel therapy is a viable alternative to current practices in the management of biventricular failure.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Interventional Cardiology Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInterventional Cardiology Journal
  • SubjectCardiology
  • BylineArticles whose byline prints “Hao A Tran”
  • BylineArticles whose byline prints “Travis L Pollema”
  • BylineArticles whose byline prints “Jorge Silva Enciso Barry H Greenberg”
  • BylineArticles whose byline prints “Denise D Barnard”
  • BylineArticles whose byline prints “Eric D Adler”
  • BylineArticles whose byline prints “Victor G Pretorius”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels